Come up with a name for your new list and we'll add to it:
Icon Bioscience raised a round of funding on August 28, 2013. Investors include
Signet Healthcare Partners.
Icon Bioscience (IBI) is a privately held company focused on the development and commercialization of novel ophthalmic pharmaceuticals, based on its proprietary drug delivery platform, Verisome. IBI's…